Annual CAPEX
$81.74 M
+$81.72 M+281775.86%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual capital expenditures is currently $81.74 million, with the most recent change of +$81.72 million (+281775.86%) on 31 December 2023. During the last 3 years, it has risen by +$81.73 million (+743027.27%). CPRX annual CAPEX is now at all-time high.CPRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$259.00 K
+$249.00 K+2490.00%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly capital expenditures is currently $259.00 thousand, with the most recent change of +$249.00 thousand (+2490.00%) on 30 September 2024. Over the past year, it has dropped by -$79.09 million (-99.67%). CPRX quarterly CAPEX is now -99.67% below its all-time high of $79.35 million, reached on 30 September 2023.CPRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.79 M
-$79.09 M-96.60%
30 September 2024
Summary:
Catalyst Pharmaceuticals TTM capital expenditures is currently $2.79 million, with the most recent change of -$79.09 million (-96.60%) on 30 September 2024. Over the past year, it has dropped by -$76.64 million (-96.49%). CPRX TTM CAPEX is now -96.60% below its all-time high of $81.88 million, reached on 30 June 2024.CPRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | -99.7% | -96.5% |
3 y3 years | +10000.0% | +280.9% | +184.3% |
5 y5 years | +10000.0% | +100.0% | +3561.0% |
CPRX CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | >+9999.0% | -99.7% | -96.6% | +9506.9% | |
5 y | 5 years | at high | >+9999.0% | -99.7% | >+9999.0% | -96.6% | >+9999.0% |
alltime | all time | at high | >+9999.0% | -99.7% | >+9999.0% | -96.6% | >+9999.0% |
Catalyst Pharmaceuticals CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $259.00 K(+2490.0%) | $2.79 M(-96.6%) |
June 2024 | - | $10.00 K(-95.0%) | $81.88 M(+0.0%) |
Mar 2024 | - | $199.00 K(-91.4%) | $81.87 M(+0.2%) |
Dec 2023 | $81.74 M(>+9900.0%) | $2.32 M(-97.1%) | $81.74 M(+2.9%) |
Sept 2023 | - | $79.35 M(>+9900.0%) | $79.43 M(>+9900.0%) |
June 2023 | - | $0.00(-100.0%) | $74.00 K(-28.2%) |
Mar 2023 | - | $74.00 K(>+9900.0%) | $103.00 K(+255.2%) |
Dec 2022 | $29.00 K(-97.2%) | $0.00(0.0%) | $29.00 K(-58.6%) |
Sept 2022 | - | $0.00(-100.0%) | $70.00 K(-49.3%) |
June 2022 | - | $29.00 K(-29.3%) | $138.00 K(-86.5%) |
Dec 2021 | $1.02 M(+9181.8%) | $41.00 K(-39.7%) | $1.02 M(+4.2%) |
Sept 2021 | - | $68.00 K(+6700.0%) | $980.00 K(+6.2%) |
June 2021 | - | $1000.00(-99.9%) | $923.00 K(+0.1%) |
Mar 2021 | - | $911.00 K(>+9900.0%) | $922.00 K(+8281.8%) |
Dec 2020 | $11.00 K(-42.1%) | $0.00(-100.0%) | $11.00 K(+3.8%) |
Sept 2020 | - | $11.00 K(-2850.0%) | $10.60 K(-43.9%) |
Dec 2019 | $19.00 K(-79.3%) | -$400.00(<-9900.0%) | $18.90 K(-75.2%) |
Sept 2019 | - | $0.00(-100.0%) | $76.10 K(-23.4%) |
June 2019 | - | $13.70 K(+144.6%) | $99.40 K(+1.8%) |
Mar 2019 | - | $5600.00(-90.1%) | $97.60 K(+6.1%) |
Dec 2018 | $92.00 K(-4.3%) | $56.80 K(+143.8%) | $92.00 K(+161.4%) |
Sept 2018 | - | $23.30 K(+95.8%) | $35.20 K(+195.8%) |
June 2018 | - | $11.90 K(+67.6%) | $11.90 K(-87.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | $96.10 K(+308.9%) | $7100.00(>+9900.0%) | $96.00 K(+8.0%) |
Sept 2016 | - | $0.00(-100.0%) | $88.90 K(-13.9%) |
June 2016 | - | $88.90 K(>+9900.0%) | $103.30 K(+341.5%) |
Dec 2015 | $23.50 K(-59.0%) | $0.00(-100.0%) | $23.40 K(-37.3%) |
Sept 2015 | - | $14.40 K(+1209.1%) | $37.30 K(+3.6%) |
June 2015 | - | $1100.00(-86.1%) | $36.00 K(-24.8%) |
Mar 2015 | - | $7900.00(-43.2%) | $47.90 K(-16.4%) |
Dec 2014 | $57.30 K(+509.6%) | $13.90 K(+6.1%) | $57.30 K(+32.0%) |
Sept 2014 | - | $13.10 K(+0.8%) | $43.40 K(+43.2%) |
June 2014 | - | $13.00 K(-24.9%) | $30.30 K(+75.1%) |
Mar 2014 | - | $17.30 K(>+9900.0%) | $17.30 K(+84.0%) |
Dec 2013 | $9400.00(-82.1%) | $0.00(0.0%) | $9400.00(-82.9%) |
Sept 2013 | - | $0.00(0.0%) | $54.90 K(0.0%) |
June 2013 | - | $0.00(-100.0%) | $54.90 K(-3.3%) |
Mar 2013 | - | $9400.00(-79.3%) | $56.80 K(+8.4%) |
Dec 2012 | $52.40 K(+1355.6%) | $45.50 K(>+9900.0%) | $52.40 K(+502.3%) |
Sept 2012 | - | $0.00(-100.0%) | $8700.00(0.0%) |
June 2012 | - | $1900.00(-62.0%) | $8700.00(+1.2%) |
Mar 2012 | - | $5000.00(+177.8%) | $8600.00(+138.9%) |
Dec 2011 | $3600.00(+24.1%) | $1800.00(>+9900.0%) | $3600.00(+100.0%) |
Sept 2011 | - | $0.00(-100.0%) | $1800.00(0.0%) |
June 2011 | - | $1800.00 | $1800.00 |
Dec 2010 | $2900.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual CAPEX year-on-year change?
- What is Catalyst Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Catalyst Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM CAPEX year-on-year change?
What is Catalyst Pharmaceuticals annual capital expenditures?
The current annual CAPEX of CPRX is $81.74 M
What is the all time high annual CAPEX for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual capital expenditures is $81.74 M
What is Catalyst Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, CPRX annual capital expenditures has changed by +$81.72 M (+281775.86%)
What is Catalyst Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of CPRX is $259.00 K
What is the all time high quarterly CAPEX for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly capital expenditures is $79.35 M
What is Catalyst Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, CPRX quarterly capital expenditures has changed by -$79.09 M (-99.67%)
What is Catalyst Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of CPRX is $2.79 M
What is the all time high TTM CAPEX for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM capital expenditures is $81.88 M
What is Catalyst Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, CPRX TTM capital expenditures has changed by -$76.64 M (-96.49%)